Massachusetts Financial Services’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-232,395
Closed -$26.8M 986
2020
Q4
$26.8M Sell
232,395
-11,291
-5% -$1.26M 0.01% 564
2020
Q3
$23.7M Buy
243,686
+75,162
+45% +$8.65M 0.01% 548
2020
Q2
$20.7M Buy
168,524
+12,282
+8% +$1.39M 0.01% 547
2020
Q1
$13.7M Buy
156,242
+8,249
+6% +$874K 0.01% 561
2019
Q4
$15.5M Buy
147,993
+46,799
+46% +$5.25M 0.01% 561
2019
Q3
$11.6M Buy
101,194
+22,481
+29% +$3.41M ﹤0.01% 594
2019
Q2
$13.6M Buy
78,713
+7,085
+10% +$1.23M 0.01% 591
2019
Q1
$12.1M Buy
+71,628
New +$10.7M 0.01% 591

Other funds holding GWPH

Massachusetts Financial Services's GWPH Position: Q1 2021 in Review

Massachusetts Financial Services sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 232,395 shares — an estimated $26.8M sold.

Massachusetts Financial Services first reported a position in GWPH in Q1 2019 and held it in 8 quarters. The position peaked at $26.8M in Q4 2020. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • Massachusetts Financial Services reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Massachusetts Financial Services sold 232,395 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $26.8M.
  • Massachusetts Financial Services first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 8 quarters.
  • Massachusetts Financial Services's GW Pharmaceuticals Plc American Depositary Shares position peaked at $26.8M in Q4 2020.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Massachusetts Financial Services's 13F filing for Q1 2021, filed 13 May 2021.